PhaseBio Pharmaceuticals 3Y Revenue Growth (per Share)

3Y Revenue Growth (per Share) of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including 3Y Revenue Growth (per Share) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 3Y Revenue Growth (per Share) for 2021 was 25.12% (a Infinity% increase from previous year)
  • Annual 3Y Revenue Growth (per Share) for 2020 was 0.0% (a NaN% decrease from previous year)
  • Annual 3Y Revenue Growth (per Share) for 2019 was 0.0% (a -100.0% decrease from previous year)
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 3Y Revenue Growth (per Share) of PhaseBio Pharmaceuticals

Most recent 3Y Revenue Growth (per Share)of PHAS including historical data for past 10 years.

Interactive Chart of 3Y Revenue Growth (per Share) of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals 3Y Revenue Growth (per Share) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 25.12%
2020 0.0%
2019 0.0%
2018 -20.08%
2017 -100.0%
2016 -100.0%

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology